Developer docs
API playgroundTry for free, no card

Search company profiles

Pitango VC

Full company profile

uuid0000c5o

Namestring
Pitango VC
Legal namestring
Pitango Ltd.
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Pitango VC is Israel's largest and longest-standing venture capital firm, founded in 1993 and headquartered in Herzliya. The firm operates three dedicated funds—Pitango First (seed and early-stage), Pitango Growth (growth-stage), and Pitango HealthTech (health and life sciences)—providing capital, board-level support, and syndicate access to technology and life-sciences startups primarily originating from Israel and increasingly from the wider European and North American deep-tech ecosystem. Across 13 funds, the firm has invested more than $3 billion into 300+ portfolio companies and recorded 100+ exits.

The firm's investment process is partner-led and organized around the three fund verticals, with specialized expertise in software, healthtech, semiconductors, clean energy, and emerging deep-tech categories such as quantum computing and AI infrastructure. In 2026 the firm began incorporating AI tooling into deal-sourcing and market intelligence, while continuing to co-invest with global venture partners and provide follow-on capital to existing portfolio companies. Recent activity includes a Sweden-based investment in Blykalla (nuclear/clean energy) and a leadership appointment within the HealthTech vertical.

Pitango's revenue model follows standard venture capital mechanics: recurring management fees on committed capital (typically around 2% per annum) plus carried interest on profitable exits. With cumulative invested capital exceeding $3 billion and a fresh $300 million fund closed in November 2025, the firm operates on a meaningful management-fee base supplemented by episodic carry realizations, with revenue predictability driven by multi-year LP commitments rather than customer churn.

Short descriptiontext

Pitango VC is Israel's largest and longest-standing venture capital firm, founded in 1993, operating three funds (First, Growth, HealthTech) with $3B+ deployed across 300+ portfolio companies and 100+ exits, serving Israeli and global technology and life-sciences startups.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
venture capital, seed stage investment, growth equity funding, healthtech investment, deep tech funding
Industry2 codes
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
2Venture Debt Providers
CodeFSANAAALPrimaryNo
NAICS code3 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Financial Investment Activities5239
  • Finance and Insurance52
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Fund management fees
TypeManaged Services
Description

Recurring management fees earned on committed and invested capital across Pitango's 13 active funds (Pitango First, Pitango Growth, Pitango HealthTech, and earlier vehicles). Standard VC industry structure with periodic capital calls across fund lifecycle.

pitango.com
2Carried interest on exits
TypeLicensing Royalties
Description

Performance-based carried interest from successful exits and IPOs across the 100+ historical exits portfolio (e.g., IPO of Via at $3.65B valuation, $1B funding round by PsiQuantum, acquisition of Vertos). Revenue realized when portfolio companies exit via acquisition or public listing.

pitango.com
3Fund capital raises (LP commitments)
TypeSubscription Recurring
Description

Capital deployment across multiple dedicated funds; recent close of $300M for Pitango First and Pitango HealthTech. New fund vintages drive forward deployment and management fee base.

pitango.com
Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Pitango First
Description

Seed and early-stage fund backing new companies and breakthrough technologies in AI, cybersecurity, quantum computing, fintech and DevOps.

pitango.com
+2 more records
Core offering1 text field

Pitango VC is a venture capital firm that deploys risk capital across three dedicated fund vehicles — Pitango First (seed and early stage), Pitango Growth (venture growth), and Pitango HealthTech (digital health, medical devices, biotech, and life sciences) — covering the full company lifecycle from seed to growth. Beyond capital, the firm operates an integrated value-add platform with in-house HR, business development, finance, legal, and marketing teams that support portfolio companies with customer introductions, operational efficiency, and fundraising, backed by a 30+ year global network of limited partners and industry leaders.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 300+ portfolio companies funded to date
+6 more records
Product overview1 text field

Pitango VC operates as a multi-fund venture capital platform rather than a single unified software product. The firm consists of three dedicated investment funds that work together as a platform-plus-modules architecture: Pitango First (Seed & Early Stage Fund backing breakthrough technologies like PsiQuantum, AI21 Labs, and Finout), Pitango Growth (Venture Growth Fund partnering with scaling companies like AppsFlyer, DriveNets, and Via), and Pitango HealthTech (Health Technology Fund specializing in life sciences ventures like QuantHealth, Visby Medical, and Altesa BioSciences). The three funds operate as distinct, complementary investment vehicles covering the full company lifecycle from seed to growth, while sharing resources such as the firm's HR, business development, finance, legal, and marketing teams, plus Pitango's global network built over 30 years. Together the funds have backed 300+ companies with $3B+ invested across 13 funds, achieving 100+ exits, with the platform leading the market in AI and quantum investments.

Product and service3 records
1Pitango First
CategorySeed & Early Stage Venture Fund
Description

Pitango First is the firm's Seed & Early Stage Fund that backs new companies and breakthrough technologies, looking for transformational change and exceptional teams. Focus areas include Cloud & Infrastructure, Generative AI, Cyber Security, Fintech & Insure Tech, Quantum Computing, Mobility & Smart City, Media & Gaming, and Sales & Marketing. Notable portfolio companies include PsiQuantum, Finout, Komodor, Quantum Source, D-ID, AI21 Labs, and Nexite.

2Pitango Growth
CategoryVenture Growth Fund
Description

Pitango Growth is the firm's growth-stage fund acting as growth partners, connecting teams with an extensive network of partners, business leaders, potential customers, and technologists to help unlock explosive growth. Focus areas include Cloud & Infrastructure, Generative AI, Food Tech, Mobility & Smart City, Cyber Security, and Digital Health. Notable portfolio companies include DriveNets, Via, AppsFlyer, Riskified, Taboola, Tomorrow.io, Formlabs, and Tulip Interfaces.

3Pitango HealthTech
CategoryHealth Technology Venture Fund
Description

Pitango HealthTech specializes in breakthrough life sciences ventures, investing across all stages of the healthtech sector with focus on digital medicine, medical devices, biopharma, and AI-driven healthcare. Notable portfolio companies include Laguna Health, Cellular Intelligence, Visby Medical, Vertos Medical, QuantHealth, Altesa BioSciences, Magenta Medical, and Connie Health.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagship Technology PartnerTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Joined as a new investor and strategic technology partner in DriveNets alongside Bessemer Venture Partners and Atreides Management. DriveNets partners with AMD, Broadcom, Dell Technologies, and Supermicro on integration initiatives for multi-vendor AI infrastructure environments — open Ethernet as a foundation for next-generation AI infrastructure.

2Biomed Israel conference
Strategic tierFlagship Event PartnerTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Pitango HealthTech Managing Partner Ittai Harel previewed a session at the upcoming Biomed Israel conference (May 12-14, 2026) focused on how AI and data science tools are beginning to transform the clinical trial sector. Strategic thought-leadership platform for the firm.

clinicaltrialsarena.com
Strategic tierFlagship Strategic PartnerTypeStrategic or Co-development PartnerAnnounced on2026-04-29
Description

Retained shareholder position in Altair Semiconductor following the spinoff; Pitango Group led the $50M initial funding round for the newly independent Israeli IoT chipmaker. Strategic partnership for go-to-market and shareholder alignment.

4Nohik Semel
Strategic tierCore Operating PartnerTypeStrategic or Co-development PartnerAnnounced on2026-04-29
Description

Appointed as new CEO of Altair Semiconductor following the spinoff from Sony and $50M funding led by Pitango Group; oversees the company's transition to 5G IoT connectivity and physical AI chips.

thefastmode.com
Strategic tierEcosystem PeerTypeOthersAnnounced on2025-12-11
Description

Israeli VC ecosystem peer. OurCrowd CEO Jon Medved and Pitango Managing General Partner Eyal Niv co-authored Forbes article 'Funding Under Fire: The Resilience Of Israeli Tech' discussing Israeli tech resilience. Ecosystem collaboration rather than direct co-investment.

Strategic tierFlagship Strategic PartnerTypeStrategic or Co-development Partner
Description

Co-developed 'The Growth Playbook' with Pitango — research on what it takes to scale past $100M+ in revenue, with insights and tips from 15+ founders. A flagship strategic co-development partnership for content and thought leadership.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Israeli venture capital firm with a multi-stage, multi-fund platform covering cybersecurity, fintech, and deep tech from seed to growth. Directly comparable as a longstanding Israeli VC competitor pursuing the same founder base.

TypeDirect peer
Description

Israeli VC with multiple funds covering early, growth, fintech, and healthtech stages. Closely comparable as a domestic multi-fund competitor with similar vertical coverage including digital health.

TypeDirect peer
Description

Israeli venture investing platform running multiple sector-focused funds. Direct peer as an Israeli VC ecosystem competitor; explicitly named as an ecosystem collaborator in joint Forbes content with Pitango.

TypeDirect peer
Description

Israeli healthtech-focused VC operating a growth fund and a venture fund. Directly comparable to Pitango HealthTech in digital health/biotech vertical; named as a co-investor alongside Pitango in Connie Health.

TypeDirect peer
Description

Early-stage Israeli VC investing in deep tech, AI infrastructure, and semiconductors. Directly comparable to Pitango First; ranked alongside Pitango in AIJourn's top 7 Israeli AI investors.

TypeEmerging player
Description

Israeli early-stage VC focused on enterprise and deep tech. Comparable as a peer Israeli seed-stage fund also ranked alongside Pitango for AI startup investing.

TypeEmerging player
Description

Israeli early-stage VC focused on cybersecurity and enterprise software. Comparable peer for Pitango First in the Israeli cybersecurity vertical; ranked alongside Pitango for AI investing.

TypeBroad incumbent
Description

Global software-focused growth equity investor with scale and a value-add platform. Comparable as a larger incumbent in the growth-stage Israeli software ecosystem, though broader in geographic and stage coverage.

TypeBroad incumbent
Description

Global multi-stage VC with a strong Israel presence and a long-running cloud/infrastructure franchise. Directly comparable as a recurring co-investor in Pitango portfolio companies (DriveNets, doubleAI, AppsFlyer).

TypeBroad incumbent
Description

Global multi-stage VC with active Israel investing in AI infrastructure and enterprise software. Comparable as a tier-one co-investor alongside Pitango in deep-tech Israeli rounds (doubleAI).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers30 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment397 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pitango VC

Venture Capitalpitango.com

Pitango VC is Israel's largest and longest-standing venture capital firm, founded in 1993, operating three funds (First, Growth, HealthTech) with $3B+ deployed across 300+ portfolio companies and 100+ exits, serving Israeli and global technology and life-sciences startups.

What Pitango VC does

Pitango VC is Israel's largest and longest-standing venture capital firm, founded in 1993 and headquartered in Herzliya. The firm operates three dedicated funds—Pitango First (seed and early-stage), Pitango Growth (growth-stage), and Pitango HealthTech (health and life sciences)—providing capital, board-level support, and syndicate access to technology and life-sciences startups primarily originating from Israel and increasingly from the wider European and North American deep-tech ecosystem. Across 13 funds, the firm has invested more than $3 billion into 300+ portfolio companies and recorded 100+ exits.

The firm's investment process is partner-led and organized around the three fund verticals, with specialized expertise in software, healthtech, semiconductors, clean energy, and emerging deep-tech categories such as quantum computing and AI infrastructure. In 2026 the firm began incorporating AI tooling into deal-sourcing and market intelligence, while continuing to co-invest with global venture partners and provide follow-on capital to existing portfolio companies. Recent activity includes a Sweden-based investment in Blykalla (nuclear/clean energy) and a leadership appointment within the HealthTech vertical.

Pitango's revenue model follows standard venture capital mechanics: recurring management fees on committed capital (typically around 2% per annum) plus carried interest on profitable exits. With cumulative invested capital exceeding $3 billion and a fresh $300 million fund closed in November 2025, the firm operates on a meaningful management-fee base supplemented by episodic carry realizations, with revenue predictability driven by multi-year LP commitments rather than customer churn.

Pitango VC firmographics

Firmographics
Name
Pitango VC
Legal name
Pitango Ltd.
Website
http://www.pitango.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
11–50 employees
Short description
Pitango VC is Israel's largest and longest-standing venture capital firm, founded in 1993, operating three funds (First, Growth, HealthTech) with $3B+ deployed across 300+ portfolio companies and 100+ exits, serving Israeli and global technology and life-sciences startups.
Ownership category
akta.pro rank

Pitango VC industry classification

Industry
Product category
Venture Capital
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Other Financial Investment Activities (5239), Finance and Insurance (52)
SIC
Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
akta.pro secondary industry
Venture Debt Providers (FSANAAAL)

Keywords

  • Venture capital
  • Seed stage investment
  • Growth equity funding
  • Healthtech investment
  • Deep tech funding

Where Pitango VC is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Markets served

Pitango VC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Fund management fees: Recurring management fees earned on committed and invested capital across Pitango's 13 active funds (Pitango First, Pitango Growth, Pitango HealthTech, and earlier vehicles). Standard VC industry structure with periodic capital calls across fund lifecycle.
  2. Carried interest on exits: Performance-based carried interest from successful exits and IPOs across the 100+ historical exits portfolio (e.g., IPO of Via at $3.65B valuation, $1B funding round by PsiQuantum, acquisition of Vertos). Revenue realized when portfolio companies exit via acquisition or public listing.
  3. Fund capital raises (LP commitments): Capital deployment across multiple dedicated funds; recent close of $300M for Pitango First and Pitango HealthTech. New fund vintages drive forward deployment and management fee base.

Go-to-market motion1 record

Distribution channels4 records

Pitango VC product offering

Product offering

Core offering

Pitango VC is a venture capital firm that deploys risk capital across three dedicated fund vehicles — Pitango First (seed and early stage), Pitango Growth (venture growth), and Pitango HealthTech (digital health, medical devices, biotech, and life sciences) — covering the full company lifecycle from seed to growth. Beyond capital, the firm operates an integrated value-add platform with in-house HR, business development, finance, legal, and marketing teams that support portfolio companies with customer introductions, operational efficiency, and fundraising, backed by a 30+ year global network of limited partners and industry leaders.

Product overview

Pitango VC operates as a multi-fund venture capital platform rather than a single unified software product. The firm consists of three dedicated investment funds that work together as a platform-plus-modules architecture: Pitango First (Seed & Early Stage Fund backing breakthrough technologies like PsiQuantum, AI21 Labs, and Finout), Pitango Growth (Venture Growth Fund partnering with scaling companies like AppsFlyer, DriveNets, and Via), and Pitango HealthTech (Health Technology Fund specializing in life sciences ventures like QuantHealth, Visby Medical, and Altesa BioSciences). The three funds operate as distinct, complementary investment vehicles covering the full company lifecycle from seed to growth, while sharing resources such as the firm's HR, business development, finance, legal, and marketing teams, plus Pitango's global network built over 30 years. Together the funds have backed 300+ companies with $3B+ invested across 13 funds, achieving 100+ exits, with the platform leading the market in AI and quantum investments.

Differentiator

Problem solved

Functional benefit

Brands

  • Pitango First: Seed and early-stage fund backing new companies and breakthrough technologies in AI, cybersecurity, quantum computing, fintech and DevOps.
  • Pitango Growth
  • Pitango HealthTech

Products and services

  • Pitango First Pitango First is the firm's Seed & Early Stage Fund that backs new companies and breakthrough technologies, looking for transformational change and exceptional teams. Focus areas include Cloud & Infrastructure, Generative AI, Cyber Security, Fintech & Insure Tech, Quantum Computing, Mobility & Smart City, Media & Gaming, and Sales & Marketing. Notable portfolio companies include PsiQuantum, Finout, Komodor, Quantum Source, D-ID, AI21 Labs, and Nexite.
  • Pitango Growth Pitango Growth is the firm's growth-stage fund acting as growth partners, connecting teams with an extensive network of partners, business leaders, potential customers, and technologists to help unlock explosive growth. Focus areas include Cloud & Infrastructure, Generative AI, Food Tech, Mobility & Smart City, Cyber Security, and Digital Health. Notable portfolio companies include DriveNets, Via, AppsFlyer, Riskified, Taboola, Tomorrow.io, Formlabs, and Tulip Interfaces.
  • Pitango HealthTech Pitango HealthTech specializes in breakthrough life sciences ventures, investing across all stages of the healthtech sector with focus on digital medicine, medical devices, biopharma, and AI-driven healthcare. Notable portfolio companies include Laguna Health, Cellular Intelligence, Visby Medical, Vertos Medical, QuantHealth, Altesa BioSciences, Magenta Medical, and Connie Health.

Quantifiable outcome

  • 300+ portfolio companies funded to date
  • +6 more outcomes

Companies that use Pitango VC

Customer profile

Named customers30 records

Segments6 records

Ideal customer profiles3 records

Pitango VC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Pitango VC partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship technology partner, flagship event partner, flagship strategic partner, core operating partner and ecosystem peer.

  • AMDflagship technology partnerStrategic or Co-development Partner · 1 June 2026Joined as a new investor and strategic technology partner in DriveNets alongside Bessemer Venture Partners and Atreides Management. DriveNets partners with AMD, Broadcom, Dell Technologies, and Supermicro on integration initiatives for multi-vendor AI infrastructure environments — open Ethernet as a foundation for next-generation AI infrastructure.
  • Biomed Israel conferenceflagship event partnerStrategic or Co-development Partner · 30 April 2026Pitango HealthTech Managing Partner Ittai Harel previewed a session at the upcoming Biomed Israel conference (May 12-14, 2026) focused on how AI and data science tools are beginning to transform the clinical trial sector. Strategic thought-leadership platform for the firm.
  • Sony Semiconductor Solutionsflagship strategic partnerStrategic or Co-development Partner · 29 April 2026Retained shareholder position in Altair Semiconductor following the spinoff; Pitango Group led the $50M initial funding round for the newly independent Israeli IoT chipmaker. Strategic partnership for go-to-market and shareholder alignment.
  • Nohik Semelcore operating partnerStrategic or Co-development Partner · 29 April 2026Appointed as new CEO of Altair Semiconductor following the spinoff from Sony and $50M funding led by Pitango Group; oversees the company's transition to 5G IoT connectivity and physical AI chips.
  • OurCrowdecosystem peerOthers · 11 December 2025Israeli VC ecosystem peer. OurCrowd CEO Jon Medved and Pitango Managing General Partner Eyal Niv co-authored Forbes article 'Funding Under Fire: The Resilience Of Israeli Tech' discussing Israeli tech resilience. Ecosystem collaboration rather than direct co-investment.
  • McKinsey & Companyflagship strategic partnerStrategic or Co-development PartnerCo-developed 'The Growth Playbook' with Pitango — research on what it takes to scale past $100M+ in revenue, with insights and tips from 15+ founders. A flagship strategic co-development partnership for content and thought leadership.

Scale indicators11 records

Recent moves7 records

Expansion highlights4 records

Pitango VC competitors and assessment

Company assessment

Direct peers

  • JVP (Jerusalem Venture Partners): Israeli venture capital firm with a multi-stage, multi-fund platform covering cybersecurity, fintech, and deep tech from seed to growth. Directly comparable as a longstanding Israeli VC competitor pursuing the same founder base.
  • Viola Ventures: Israeli VC with multiple funds covering early, growth, fintech, and healthtech stages. Closely comparable as a domestic multi-fund competitor with similar vertical coverage including digital health.
  • OurCrowd: Israeli venture investing platform running multiple sector-focused funds. Direct peer as an Israeli VC ecosystem competitor; explicitly named as an ecosystem collaborator in joint Forbes content with Pitango.
  • aMoon Fund: Israeli healthtech-focused VC operating a growth fund and a venture fund. Directly comparable to Pitango HealthTech in digital health/biotech vertical; named as a co-investor alongside Pitango in Connie Health.
  • Grove Ventures: Early-stage Israeli VC investing in deep tech, AI infrastructure, and semiconductors. Directly comparable to Pitango First; ranked alongside Pitango in AIJourn's top 7 Israeli AI investors.

Emerging players

  • StageOne Ventures: Israeli early-stage VC focused on enterprise and deep tech. Comparable as a peer Israeli seed-stage fund also ranked alongside Pitango for AI startup investing.
  • Glilot Capital Partners: Israeli early-stage VC focused on cybersecurity and enterprise software. Comparable peer for Pitango First in the Israeli cybersecurity vertical; ranked alongside Pitango for AI investing.

Broad incumbents

  • Insight Partners: Global software-focused growth equity investor with scale and a value-add platform. Comparable as a larger incumbent in the growth-stage Israeli software ecosystem, though broader in geographic and stage coverage.
  • Bessemer Venture Partners: Global multi-stage VC with a strong Israel presence and a long-running cloud/infrastructure franchise. Directly comparable as a recurring co-investor in Pitango portfolio companies (DriveNets, doubleAI, AppsFlyer).
  • Lightspeed Venture Partners: Global multi-stage VC with active Israel investing in AI infrastructure and enterprise software. Comparable as a tier-one co-investor alongside Pitango in deep-tech Israeli rounds (doubleAI).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Pitango VC social profiles

Digital presence

Pitango VC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pitango VC leadership team

Management profile

Number of profiles

Profiles18 records

Pitango VC subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Pitango VC funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pitango VC M&A and investment

M&A and investment

M&A

Investments397 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pitango VC

What does Pitango VC do?

Pitango VC is a venture capital firm that deploys risk capital across three dedicated fund vehicles — Pitango First (seed and early stage), Pitango Growth (venture growth), and Pitango HealthTech (digital health, medical devices, biotech, and life sciences) — covering the full company lifecycle from seed to growth. Beyond capital, the firm operates an integrated value-add platform with in-house HR, business development, finance, legal, and marketing teams that support portfolio companies with customer introductions, operational efficiency, and fundraising, backed by a 30+ year global network of limited partners and industry leaders.

Is Pitango VC a public or private company?

Pitango VC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Pitango VC founded?

Pitango VC was founded in 1993. It employs 11 to 50 people.

Where is Pitango VC based?

Pitango VC is headquartered in Herzliya, Israel, in the Middle East region.

How does Pitango VC make money?

Three revenue lines are on record. Fund management fees are the primary driver. The others are carried interest on exits and fund capital raises (LP commitments).

Who are Pitango VC's main competitors?

Direct peers on record are JVP (Jerusalem Venture Partners), Viola Ventures, OurCrowd, aMoon Fund and Grove Ventures. Emerging players are StageOne Ventures and Glilot Capital Partners. Broad incumbents are Insight Partners, Bessemer Venture Partners and Lightspeed Venture Partners.

Does Pitango VC have an API?

No public API is recorded for Pitango VC.

What industry is Pitango VC in?

Pitango VC's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAL, Venture Debt Providers. Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecurityWeekCatch Raises $5 Million for AI Executive Assistant With GuardrailsCatch, an AI admin assistant for executives, raised $5 million co-led by Entrée Capital and Pitango. The startup's product handles scheduling, travel, and sensitive communications with guardrails and human-in-the-loop decisions. It is priced at $99 per month.The SaaS NewsCatch Raises $5M SeedCatch, a US startup, emerged from stealth with $5 million in seed funding led by Entrée Capital and Pitango. The company will use the funds to expand its agentic AI platform for executive administrative tasks, including email, scheduling, and travel.FinSMEsCatch Raises $5M in Seed FundingCatch, a Tel Aviv-based AI and enterprise productivity startup, raised $5M in seed funding led by Entrée Capital and Pitango. The company will use the capital to expand its backend engineering teams, train proprietary administrative reasoning models, and scale go-to-market efforts in North America and Europe.Pulse 2.0Catch Raises $5 Million Seed Round To Launch Agentic Admin Assistant For Business LeadersCatch, an agentic admin assistant for business leaders, raised $5 million in seed funding co-led by Entrée Capital and Pitango. The company reports its platform has scheduled over 12,000 meetings, delegated 20,000 tasks, and handled 200,000 emails. It targets midsized U.S. businesses and enterprises.Tech Funding NewsPitch deck: The investor behind Weavy’s Figma $200M exit raises $5M for AI agent Catch — TFNCatch, an AI agent for executive administration, raised $5 million in seed funding led by Entrée Capital and Pitango. The service, launched four months ago, has hundreds of paying customers and plans to use the funds to improve its travel product and grow its user base.PR NewswireAltesa BioSciences Named Recipient of the 2026 Georgia Life Sciences Golden Helix Award for Financing Deal of the YearAltesa BioSciences was named recipient of the 2026 Georgia Life Sciences Golden Helix Award for Deal of the Year for its oversubscribed $75 million Series B financing. The round, led by Forbion with Sanofi participation, supports development of vapendavir, an antiviral for COPD, and will be presented at the August 25 summit in Sandy Springs, GA.MorningstarAltesa BioSciences Named Recipient of the 2026 Georgia Life Sciences Golden Helix Award for Financing Deal of the YearAltesa BioSciences was named recipient of the 2026 Georgia Life Sciences Golden Helix Award for Financing Deal of the Year. The award recognizes its oversubscribed $75 million Series B financing led by Forbion, which supports its lead asset vapendavir for COPD and asthma. The company will present the award at the Georgia Life Sciences Summit on August 25.GlobesIsraeli clinical trial simulation co QuantiHealth raises $45mIsraeli AI-driven clinical trial simulation company QuantiHealth announced completion of a $45 million Series B financing round led by Qumra Capital, with participation from multiple investors including Pitango HealthTech, Sanofi Ventures, Bertelsmann Healthcare Investments, and others. The company will use the funds to scale enterprise-wide impact and accelerate adoption of simulation-first clinical development, allowing life sciences enterprises to test and optimize clinical trials through AI-driven simulation before enrolling patients or committing capital. QuantiHealth notes that over 90% of drugs entering clinical development ultimately fail, with 75% failing due to efficacy and safety concerns.CTech“Saying AI today is like saying software”Eyal Niv, Managing Partner at VC fund Pitango, spoke at the Summer Cocktail Event hosted by Fusion VC in Tel Aviv, comparing AI to software as an essential component for any high-tech company. He noted that the AI revolution combined with massive capital investments from global tech giants now allows Israeli founders to develop entire technology stacks from day one. Niv also observed that the accelerating speed of the industry has raised the bar for entrepreneurs, requiring them to simultaneously execute sales, marketing, and product development at international standards.BioSpaceConnie Health Announces Acquisition of Clearlink Insurance Agency and Series B Funding to Accelerate Growth in MedicareConnie Health completed its acquisition of Clearlink's Medicare business, its 10th acquisition, and announced a $40 million Series B led by HealthQuest Capital. The round brings total funding to $85 million, supporting further acquisitions and agent network growth.